Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ecovia Bio, formerly Ecovia Renewables, is a private U.S. biotechnology and advanced materials company developing and commercializing biobased, biodegradable polymers made through microbial fermentation. The company emerged from University of Michigan research and focuses on polyglutamic acid-based materials positioned as alternatives to petrochemical polyacrylates and polyacrylamides. Its products target applications in personal care, hygiene, agriculture, packaging, food, medical, and industrial formulations rather than therapeutics. Ecovia markets its platform as feedstock-flexible and cost-effective, with an emphasis on reducing greenhouse gas emissions and microplastic pollution while improving product performance. The company appears to have moved from R&D into early commercial manufacturing and product sales, including U.S. production of polyglutamic acid materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecovia Bio.